JHJingang Huang

Jingang Huang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jingang Huang has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A variety of death modes of neutrophils and their role in the etiology of autoimmune diseases

    by Yanhong Li, Yinlan Wu, Jingang Huang, Xue Cao, Qiyuan An, Yun Peng, Yi Zhao, Yubin Luo

    Summary: Neutrophils are important in the context of innate immunity and actively contribute to the progression of diverse autoimmune disorders. Distinct death mechanisms of neutrophils may exhibit specific and pivotal roles in autoimmune diseases and disease pathogenesis through the orchestration of immune homeostasis, the facilitation of autoantibody production, the induction of tissue and organ damage, and the incitement of pathological alterations. In recent years, more studies have provided in‐depth examination of various neutrophil death modes, revealing nuances that challenge conventional understanding and underscoring their potential clinical utility in diagnosis and treatment. This review explores the multifaceted processes and characteristics of neutrophil death, with a focus on tailored investigations within various autoimmune diseases. It also highlights the potential interplay between neutrophil death and the landscape of autoimmune disorders. The review encapsulates the pertinent pathways implicated in various neutrophil death mechanisms across diverse autoimmune diseases while also charts possible avenues for future research.


  • UCHL1 aggravates skin fibrosis through an IGF ‐1‐induced Akt/ mTOR / HIF ‐1α pathway in keloid

    by Chipeng Guo, Lizhu Liang, Jingbin Zheng, Yang Xie, Xiaonan Qiu, Guozhen Tan, Jingang Huang, Liangchun Wang

    Keloid is a heterogeneous disease featured by the excessive production of extracellular matrix. It is a great challenge for both clinicians and patients regarding the exaggerated and uncontrolled outgrowth and the therapeutic resistance of the disease. In this study, we verified that UCHL1 was drastically upregulated in keloid fibroblasts. UCHL1 had no effects on cell proliferation and migration, but instead promoted collagen I and α‐SMA expression that was inhibited by silencing UCHL1 gene and by adding in LDN‐57444, a pharmacological inhibitor for UCHL1 activity as well. The pathological process was mediated by IGF‐1 promoted Akt/mTOR/HIF‐1α signaling pathway because inhibition of any of them could reduce the expression of collagen I and α‐SMA driven by UCHL1 in fibroblasts. Also, we found that UCHL1 expression in keloid fibroblasts was promoted by M2 macrophages via TGF‐β1. These findings extend our understanding of the pathogenesis of keloid and provide potential therapeutic targets for the disease.